meRfi®-GM
Pseudomonas aeruginosa
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Pseudomonas aeruginosa is a type of bacterium that is classified as Gram-negative, meaning it has a specific cell wall structure that makes it more resistant to certain antibiotics. This bacterium is known as an opportunistic pathogen, which means it primarily causes infections in individuals whose immune systems are weakened or compromised. It was first discovered in 1882 by a scientist named Gersard, who isolated it from pus found in wounds
In intensive care units (ICUs), Pseudomonas aeruginosa is responsible for up to 16.2% of infections
Pseudomonas aeruginosa is linked to several serious health issues, including ventilator-associated pneumonia (VAP), infections at surgical sites, [urinary tract infections (UTIs](brain://KcoE5QnVOE-8W0s_gEAE8w/…
References (Sources)
- Antibiotic-Resistant Pseudomonas aeruginosa: Current Challenges and Emerging Alternative Therapies
- Assigning chemoreceptors to chemosensory pathways in Pseudomonas aeruginosa
- Endogenous membrane stress induces T6SS activity in Pseudomonas aeruginosa
- Functional food science and gastrointestinal physiology and functionReview
- Pseudomonas aeruginosa and Other Pseudomonas Species
- Pseudomonas exotoxin A: From virulence factor to anti-cancer agent
- The Pseudomonas aeruginosa patatin-like protein PlpD is the archetype of a novel Type V secretion system